SPRO
Spero Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD1.38
-0.06 (-4.17%)
Rating:A-
Company Profile
CEO
Esther Rajavelu
IPO Date
2017-11-02
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$1.39
Prev. Close
$1.44
Day Low
$1.37
Day High
$1.44
52W Low
$1.37
52W High
$3.08
Market Cap
$0.08B
Volume
2.17M